New drug cocktail targets Hard-to-Treat myeloma
NCT ID NCT07096778
First seen Feb 06, 2026 · Last updated Jun 10, 2026 · Updated 20 times
Summary
This study tests a new drug, inobrodib, combined with two standard medicines (pomalidomide and dexamethasone) in 100 adults whose multiple myeloma has come back or no longer responds to available therapies. The goal is to see how well the combination shrinks or controls the cancer and to learn more about its side effects. Participants will know they are receiving the study treatment, and the results will help determine if this approach offers a new option for managing this blood cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA REFRACTORY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
American Oncology Partners, PA
RECRUITINGBethesda, Maryland, 20817, United States
-
Barts Health NHS Trust
RECRUITINGLondon, EC1A 7BE, United Kingdom
-
Cleveland Clinic
RECRUITINGCleveland, Ohio, 44195, United States
-
Fred Hutchinson Cancer Center
RECRUITINGSeattle, Washington, 98109, United States
-
H Lee Moffitt Cancer Center & Research Institute
RECRUITINGTampa, Florida, 33612, United States
-
Imperial College Healthcare NHS Trust, Hammersmith Hospital
RECRUITINGLondon, W12 0HS, United Kingdom
-
King's College Hospital NHS Foundation Trust
RECRUITINGLondon, SE5 9RS, United Kingdom
-
Levine Cancer Institute
RECRUITINGCharlotte, North Carolina, 28204, United States
-
Royal Marsden NHS Foundation Trust
RECRUITINGSutton, London, SM2 5PT, United Kingdom
-
Rutgers Cancer Institute of New Jersey
RECRUITINGNew Brunswick, New Jersey, 08901, United States
-
The Christie NHS Foundation Trust
RECRUITINGWithington, Greater Manchester, M20 4BX, United Kingdom
-
The Clatterbridge Cancer Centre NHS Foundation Trust
RECRUITINGBebington, Wirral, CH63 4JY, United Kingdom
-
University Hospital of Wales
RECRUITINGCardiff, Wales, CF14 4XW, United Kingdom
-
University of California, San Francisco
RECRUITINGSan Francisco, California, 94143, United States
-
University of Nebraska Medical Center
RECRUITINGOmaha, Nebraska, 68198, United States
-
University of Pennsylvania, Abramson Cancer Center
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
-
Wake Forest University Health Sciences
RECRUITINGWinston-Salem, North Carolina, 27157, United States
-
Washington University School of Medicine
RECRUITINGSt Louis, Missouri, 63110, United States
-
Western General Hospital
RECRUITINGEdinburgh, EH4 2XU, United Kingdom
-
Winship Cancer Institute
RECRUITINGAtlanta, Georgia, 30322, United States
Conditions
Explore the condition pages connected to this study.